The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
OTC:ORPOF
|
FR |
|
SanBio Co Ltd
OTC:SNBOY
|
JP |
|
L
|
LG Electronics Inc
LSE:39IB
|
KR |
|
i-mobile Co Ltd
OTC:IMCLF
|
JP |
|
H
|
Honda Motor Co Ltd
XMUN:HDM
|
JP |
|
M
|
Mcf Energy Ltd
XMUN:DC6
|
CA |
|
E
|
Eckert & Ziegler SE
SWB:EUZ
|
DE |
|
DGR Global Ltd
F:D4A
|
AU |
|
L
|
Logitech international SA
SWB:LTEC
|
CH |
|
A
|
Abb Ltd
DUS:ABJ
|
CH |
|
A
|
Allstate Corp
DUS:ALS
|
US |
|
O
|
Omnicom Group Inc
DUS:OCN
|
US |
|
N
|
Novartis AG
XETRA:NOT
|
CH |
|
J
|
Jungheinrich AG
DUS:JUN3
|
DE |
|
F
|
Fuelcell Energy Inc
XMUN:FEY
|
US |
|
Bank Danamon Indonesia Tbk PT
OTC:PBDIF
|
ID |
|
Novus Holdings Ltd
OTC:NVSHF
|
ZA |
|
S
|
Stef SA
DUS:STP
|
FR |
|
B
|
Belden Inc
XMUN:QCTA
|
US |
|
I
|
Innoviva Inc
XMUN:HVE
|
US |
|
M
|
MTU Aero Engines AG
XHAN:MTX
|
DE |
|
A
|
Amoeba SA
XMUN:A1H
|
FR |
|
H
|
Haverty Furniture Companies Inc
F:25F
|
US |
|
I
|
Investec PLC
JSE:INPPR
|
UK |
OSE Immunotherapeutics SA (ORPOF)’s 12-month stock price forecast through March 2023 has a consensus target of $58.8, implying 407% upside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ORPOF is 58.8 USD with a low forecast of 49.22 USD and a high forecast of 131.03 USD.
The compound annual growth rate for Revenue over the next 3 years is 234%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more